Get the Stockscreener App
2.31
2.94%
-0.07
After Hours:
2.31
Alaunos Therapeutics Inc stock is traded at $2.31, with a volume of 33,867.
It is down -2.94% in the last 24 hours and down -5.33% over the past month.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.
See More
Previous Close:
$2.38
Open:
$2.35
24h Volume:
33,867
Relative Volume:
0.24
Market Cap:
$5.10M
Revenue:
-
Net Income/Loss:
$-36.46M
P/E Ratio:
-0.9625
EPS:
-2.4
Net Cash Flow:
$-30.20M
1W Performance:
+6.94%
1M Performance:
-5.33%
6M Performance:
+54.00%
1Y Performance:
-3.75%
1-Day Range:
$2.23
$2.39
1-Week Range:
$2.105
$2.39
52-Week Range:
$1.3137
$6.20
Alaunos Therapeutics Inc Stock (TCRT) Company Profile
Name
Alaunos Therapeutics Inc
Sector
Industry
Phone
(346) 355-4099
Address
2617 BISSONNET ST, HOUSTON
Compare TCRT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TCRT
Alaunos Therapeutics Inc
|
2.31 | 4.83M | 0 | -36.46M | -30.20M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Alaunos Therapeutics Inc Stock (TCRT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-04-22 | Resumed | Wells Fargo | Overweight |
Alaunos Therapeutics Inc Stock (TCRT) Latest News
visual analytics tools that track alaunos therapeutics inc. performanceJuly 2025 Update & Daily Chart Pattern Signals - Newser
Will breakout in Alaunos Therapeutics Inc. lead to full recoveryPortfolio Gains Summary & Free Expert Verified Stock Movement Alerts - Newser
Statistical indicators supporting Alaunos Therapeutics Inc.’s strengthSwing Trade & Reliable Intraday Trade Plans - Newser
Is Alaunos Therapeutics Inc. stock reversal real or fake2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - Newser
Real time pattern detection on Alaunos Therapeutics Inc. stockJuly 2025 Earnings & Expert Verified Movement Alerts - Newser
Comparing Alaunos Therapeutics Inc. in custom built stock radars2025 Pullback Review & Expert Approved Momentum Ideas - Newser
Analyzing Alaunos Therapeutics Inc. with multi timeframe chartsEarnings Summary Report & Expert Curated Trade Setup Alerts - Newser
Using portfolio simulators with Alaunos Therapeutics Inc. includedBear Alert & Real-Time Volume Surge Alerts - Newser
Is Alaunos Therapeutics Inc. forming a bottoming basePortfolio Update Report & Weekly High Conviction Trade Ideas - Newser
What’s next for Alaunos Therapeutics Inc. stock pricePortfolio Gains Summary & Free Safe Entry Trade Signal Reports - Newser
Signal strength of Alaunos Therapeutics Inc. stock in tech scanners - Newser
Can a trend reversal in Alaunos Therapeutics Inc. lead to recoveryPortfolio Update Summary & Safe Capital Growth Tips - Newser
Published on: 2025-09-12 01:15:26 - Newser
How to integrate Alaunos Therapeutics Inc. into portfolio analysis toolsTrade Risk Assessment & Low Volatility Stock Suggestions - Newser
Live market analysis of Alaunos Therapeutics Inc.2025 Breakouts & Breakdowns & Free Reliable Trade Execution Plans - Newser
Visual analytics tools that track Alaunos Therapeutics Inc. performanceJuly 2025 Macro Moves & Community Verified Swing Trade Signals - Newser
Is a relief rally coming for Alaunos Therapeutics Inc. holdersWeekly Stock Analysis & Short-Term Trading Alerts - Newser
Analyzing drawdowns of Alaunos Therapeutics Inc. with statistical toolsWeekly Trade Analysis & Safe Swing Trade Setups - Newser
What candlestick patterns are forming on Alaunos Therapeutics Inc.July 2025 Technicals & Verified Entry Point Signals - Newser
How to monitor Alaunos Therapeutics Inc. with trend dashboards2025 Top Decliners & Technical Entry and Exit Alerts - Newser
Alaunos Therapeutics’ Pediatric Brain Tumor Study Update: Implications and Insights - MSN
Will Alaunos Therapeutics Inc. continue its uptrend2025 Geopolitical Influence & Long Hold Capital Preservation Plans - Newser
What technical models suggest about Alaunos Therapeutics Inc.’s comebackJuly 2025 Drop Watch & Community Shared Stock Ideas - Newser
Reversal indicators forming on Alaunos Therapeutics Inc. stockJuly 2025 Retail & Short-Term Trading Alerts - Newser
Earnings visualization tools for Alaunos Therapeutics Inc.July 2025 Outlook & Real-Time Stock Price Movement Reports - Newser
Measuring Alaunos Therapeutics Inc.’s beta against major indicesJuly 2025 Institutional & Stepwise Swing Trade Plans - Newser
What’s the recovery path for long term holders of Alaunos Therapeutics Inc.Trend Reversal & Daily Volume Surge Signals - Newser
How sentiment analysis helps forecast Alaunos Therapeutics Inc.Quarterly Trade Review & Free Community Supported Trade Ideas - Newser
What machine learning models say about Alaunos Therapeutics Inc.July 2025 Gainers & Free Growth Oriented Trading Recommendations - Newser
Volume spikes in Alaunos Therapeutics Inc. stock – what they meanQuarterly Trade Summary & AI Forecasted Entry and Exit Points - Newser
Published on: 2025-09-09 02:16:35 - Newser
Quant Models Detect Momentum Reversal in Alaunos Therapeutics Inc.July 2025 Pullbacks & Free Technical Pattern Based Buy Signals - beatles.ru
Forecasting Alaunos Therapeutics Inc. price range with options dataTrade Exit Report & AI Powered Market Trend Analysis - Newser
Using flow based indicators on Alaunos Therapeutics Inc.Earnings Performance Report & Capital Efficiency Focused Ideas - Newser
Alaunos Therapeutics Inc Stock (TCRT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):